Cochrane Abstracts
Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Orthodontic Treatment for Prominent Upper Front Teeth (Class II Malocclusion) in Children and Adolescents." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431468/all/Orthodontic_treatment_for_prominent_upper_front_teeth__Class_II_malocclusion__in_children_and_adolescents.
Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431468/all/Orthodontic_treatment_for_prominent_upper_front_teeth__Class_II_malocclusion__in_children_and_adolescents. Accessed January 17, 2025.
Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431468/all/Orthodontic_treatment_for_prominent_upper_front_teeth__Class_II_malocclusion__in_children_and_adolescents
Orthodontic Treatment for Prominent Upper Front Teeth (Class II Malocclusion) in Children and Adolescents [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431468/all/Orthodontic_treatment_for_prominent_upper_front_teeth__Class_II_malocclusion__in_children_and_adolescents.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents
ID - 431468
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431468/all/Orthodontic_treatment_for_prominent_upper_front_teeth__Class_II_malocclusion__in_children_and_adolescents
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
